A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

This is a three year open-label study in subjects with axillary hyperhidrosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperhidrosis Skin Diseases Skin and Connective Tissue Diseases Sweat Gland Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Pinneberg, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Marked axillary hyperhidrosis

Exclusion criteria

Previous use of botulinum toxin for hyperhidrosis

Treatment and study plan

Botulinum toxin type A

Biological

100 U, repeated treatments at > 4 month intervals up to Month 32, over a 36-month study period

Other names: BOTOX®

Primary outcomes

Assessment of axillary sweat production

Time frame: Every 4 Months

Secondary outcomes

Patient reported health outcome measures

Time frame: 1 Month Post-Treatment Visit

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2003
Primary completion: 2007
Study completion: 2007
First posted: Sep 15, 2005
Registry last updated: Sep 29, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed